Skip to main content

Table 1 Eight Caucasian male subjects were enrolled into the study. All subjects had four PET/CT scans, except subject 122 who declined further participation after the first two scanning sessions for availability reasons

From: The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans

Subject

Age (years)

Weight (kg)

BMI (kg/m2)

Dose of radioactivity (MBq)

105

54

76.1

25.7

12.77

110

53

72.2

22.8

14.53

122

54

68.6

23.5

14.24

123

60

92.3

27.6

13.27

125

53

91.8

27.4

14.64

127

56

70.2

21.4

14.72

132

54

73.0

20.9

15.03

135

56

83.1

23.3

13.06